Syngene International Ltd

SYNGENE NSE Healthcare Healthcare Research, Analytics & Technology
Nifty 500 Smallcap 50 Smallcap 100 Smallcap 250
₹382.65
-0.35%
Delayed · cached 15 min

Fair value analysis

SYNGENE
Syngene International Ltd
Healthcare›Healthcare Research, Analytics & Technology
₹384.00
Close used for this calculation
₹240.74Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
39/100
Profitability11/25
Returns5/25
Balance Sheet21/25
Efficiency2/25
Growth1/25
Average
Quality radar
39Prof.11/25Ret.5/25Eff.2/25B.Sht21/25Growth1/25

Consensus fair value

₹240.74
Above FV
▼ -37.3% against the close used
Model range ₹7.86 – ₹347.28
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹7.86Fair value₹240.74Bull₹347.28
FairClose
52-week traded range
52W low ₹384.0052W high ₹670.80

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Syngene International Ltd closed at ₹384.00, 59.5% above the consensus fair value of ₹240.74 drawn from 9 valuation models.

Financial DNA score 39/100 — Average. P/E of 52.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹170.26
-55.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=1%, r=10%, tg=3%, n=10yr
Graham Number
₹140.91
-63.3%
√(22.5 × EPS × BVPS)
EPS=7.86, BVPS=112.28 · outside Graham range (P/E 52.2, P/B 3.4) — asset-light, treat as a rough floor
Graham Formula
₹76.64
-80.0%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=1%, FD=7%
P/E Fair Value
₹305.36
-20.5%
EPS × 38.85x (sector P/E)
EPS=7.86, Sector P/E=38.85x
Peter Lynch (PEG)
₹7.86
-98.0%
EPS × Growth% (PEG = 1 is fair)
EPS=7.86, g=1%
EV/EBITDA
₹347.28
-9.6%
(EBITDA × 10.5x − Net Debt) ÷ Shares
EBITDA=13.74B
Book Value (P/B)
₹76.67
-80.0%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=112.28, ROE=7.8%, g=3%, r=10%
Reverse DCF
₹384.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 19.2% | Historical: 1%
Margin of Safety
₹129.97
-66.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=173.29, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.